Biogen Inc.

United States of America

 
Total IP 18
Total IP incl. subs 943 (+ 926 for subs)
Total IP Rank # 83,170
IP Activity Score 1.8/5.0    10
IP Activity Rank # 90,034
IP AS incl. subs 3.1/5.0    504
Stock Symbol
ISIN US09062X1037
Market Cap. 22,800M  (USD)
Industry Drug Manufacturers - Major
Sector Healthcare

Patents

Trademarks

7 0
2 0
9 0
0
 
Last Patent 2024 - Therapeutic and diagnostic metho...
First Patent 1978 - Protein synthesis

Subsidiaries

7 subsidiaries with IP (756 patents, 170 trademarks)

3 subsidiaries without IP

 Register for free to unlock the subsidiary list

Latest Inventions, Goods, Services

2023 Invention Therapeutic and diagnostic methods for multiple sclerosis. The present invention is directed to m...
2021 Invention Process for preparing alpha-carboxamide pyrrolidine derivatives. The disclosure relates to novel...
Invention Process for preparing spiro derivatives. The invention relates to a novel process for preparing ...
Invention Diagnostic method. The invention relates to a method of diagnosing a paroxysmal pain disorder, s...
2020 Invention Method for treating joint damage. Methods of treating joint damage in a subject eligible for tre...
Invention Processes for preparing alpha-carboxamide pyrrolidine derivatives. The disclosure provides proce...
Invention Processes for preparing alpha-carboxamide pyrrolidine derivatives. The disclosure provides proces...
Invention Processes for preparing alpha-carboxamide pyrrolidine derivatives. SRR)-5-(4-((2-fluorobenzyl)oxy...
2019 Invention Method for treating joint damage. Methods of treating joint damage in a subject eligible for trea...
2018 Invention Process for preparing spiro derivatives. The invention relates to a novel process for preparing S...
Invention Process for preparing spiro derivatives. The invention relates to a novel process for preparing s...
Invention Process for preparing alpha-carboxamide pyrrolidine derivatives. The invention relates to a novel...
Invention Process for preparing alpha-carboxamide pyrolidine derivatives. The invention relates to a novel ...
Invention Novel salts. The invention relates to novel salts of 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)...
Invention Novel salts. The invention relates to novel salts of 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)-...
Invention Novel crystalline forms. The present invention is directed to novel crystalline forms of 5-(4-{[(...
Invention Treatment of autoimmune diseases. The present invention concerns treatment of autoimmune disease...
2017 Invention Treatment of diffuse large-cell lymphoma with anti-cd20 antibody. The present invention concerns ...
Invention Novel dosage regimen. The present invention is directed to a novel method of treating a disease o...
2016 Invention Treatment of diffuse large-cell lymphoma with anti-cd20 antibody. The present invention concerns...
Invention Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody. New ...
Invention Methods of treating inflammatory and autoimmune diseases with natalizumab. Natalizumab is a safe...
Invention Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody. New c...
2015 Invention Compositions and methods for treatment of sickle cell disease. This invention relates to methods...
Invention Compositions and methods for treatment of sickle cell disease. This invention relates to methods ...
2014 Invention Methods for increasing polypeptide recovery. The present invention pertains to a method for purif...
Invention Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt...
2012 Invention Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies. New...
2011 Invention Enrichment and concentration of select product isoforms by overloaded bind and elute chromatograp...
2010 Invention Treatment of vasculitis. The present invention concerns treatment of autoimmune diseases with ant...
Invention Use of bcma as an immunoregulatory agent. The disclosure relates to B-cell maturation antigen (B...
Invention Methods of treating inflammatory and autoimmune diseases with natalizumab. Natalizumab is a safe ...
2009 Invention Treatment of chronic lymphocytic leukemia using anti-cd20 antibodies. Chronic Lymphocytic Leukemi...
2007 Invention Methods of treating rheumatoid arthritis with 7c10 and 16c10 cd80-specific antibodies. The presen...
2000 Invention Treatment of aggressive non-hodgkins lymphoma with anti-cd20 antibody. This invention concerns me...
Invention Treatment of autoimmune diseases. Methods are disclosed of treating rheumatoid arthritis in a hum...
1999 Invention Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti...